Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by PLITheOneon Oct 08, 2021 1:40pm
165 Views
Post# 33989551

RE:RE:Current debt

RE:RE:Current debt

It's debt that holds all IP as collateral through Thomvest company, SALP in the Cayman Islands, a shell company for when they close Liminal  

SALP must have also received some of the voucher cash with the selling of the IP, patents  



GunnerG wrote: you can find it on the Liminal website in the financial statements.

It is called "long term debt".

 

Greenviolino wrote: Anyone could remind us where the debt on the balance sheet stands at ? Thanks. 




<< Previous
Bullboard Posts
Next >>